Agista held an 11.7% in Dendrio Solutions and the fund’s investment generated an Internal Rate of Return of 22% and a 60% return in two years and a half.
“Our strategy has from the very beginning envisaged the capital infusion in Dendrio in a bid to support it in strengthening its footprint on the market via M&A. A strategy that we can say has borne fruit. Thus, the decision to exit has come naturally in this process,” stated Anca Manitiu, an executive member of Agista board team.
As regards the investment in Fort, Agista has increased its holding from 4.4% to 38%, and, together with Impetum Investments, has become a majority shareholder, with an overall 63.3% stake.
(English version by Catalina Apostoiu)